1. Abbasi MM, Helli S, Monfaredan A, Jahanban-Esfahlan R (2015) Hesa-A improves clinical outcome of oral carcinoma by affecting p53 gene expression in vivo. Asian Pac J Cancer Prev 16:4169–4172
2. Abou-Seif MA, El-Naggar MM, El-Far M, Ramadan M, Salah N (2003) Prevention of biochemical changes in gamma-irradiated rats by some metal complexes. Clin Chem Lab Med 41:926–933
3. Ahmadi A, Mohagheghi MA, Fazeli MS, Nahavandian B, Bashardoost N, Jarahi AM, Gharipoor M (2005a) HESA-A: new treatment for breast cancer and choroidal metastasis. Med Sci Monit 11:300–303
4. Ahmadi A, Naderi G, Asgary S (2005b) Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamide-induced hepatic damage in rabbits. Drugs Exp Clin Res 31:1–6
5. Ahmadi A, Mohagheghi M, Karimi M, Golestanha SA, Naseri M (2009) Anticancer effects of HESA-A in patients with metastatic colon cancer. Integr Cancer Ther 8:71–74